SHODHAN PATEL: Open Payments
NPI 1518975564 · NEW PORT RICHEY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 17 payments from 9 companies in 2025. Trend: 2023 $318 · 2024 $692 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $91 |
| Lundbeck LLC | 2 | $45 |
| Vanda Pharmaceuticals Inc. | 2 | $43 |
| Almatica Pharma LLC | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Alkermes, Inc. | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: REXULTI, AUSTEDO XR, HETLIOZ, LOREEV XR, UZEDY, INGREZZA, SPRAVATO, LYBALVI.
Industry payments across FL — which companies pay providers there.
